Genesco Inc. GCO
Set alert
36.65 USD -0.97 -2.57%
As of Nov 3, 1:02 PM ET
36.59 Day range 37.75
21.95 52-week range 42.72
- YTD
- +47.97%
- 1 year
- +23.62%
- Open
- 37.75
- Prev close
- 37.62
- Mkt cap
- 396.45M
- Vol
- 36.58K
- Avg vol
- 180.96K
- EPS
- 3.86
- P/E
- 9.49
- Div yield
- 0.00%
More statistics
- Low
- 36.59
- High
- 37.75
- Forward P/E
- 20.55
- Beta
- 2.41
- Short ratio
- 3.81
- Inst. own
- 92.56%
- Dividend
- 0.00
- Ex-div date
- Apr 8, 1973
- 50-d avg
- 32.75
- 200-d avg
- 28.36
- 1y target
- 40.00
Analyst view
Consensus: hold
Hold
Price target (mean) 40.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.24 | 3.22 – 3.25 | 2.59 | +24.9% | 736.11M | -0.4% | 2 |
| Next quarter | -1.46 | -1.46 – -1.46 | -2.10 | +30.5% | 462.00M | +1.0% | 1 |
| Current year | 0.81 | 0.72 – 0.90 | 0.56 | +44.6% | 2.32B | -0.4% | 2 |
| Next year | 2.05 | 1.49 – 2.60 | 0.81 | +152.5% | 2.36B | +1.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 5, 2024 | B. Riley Securities | Downgrade | Buy | Neutral |
| Dec 15, 2023 | B. Riley Securities | Initiated | — | Buy |
| Dec 4, 2023 | Seaport Global | Downgrade | Buy | Neutral |
| Mar 28, 2023 | Seaport Global | Upgrade | Neutral | Buy |
| Aug 30, 2022 | Seaport Global | Downgrade | Buy | Neutral |
| Jan 18, 2022 | Seaport Global | Initiated | — | Buy |
| Apr 6, 2020 | Susquehanna | Maintained | — | Positive |
| Mar 13, 2020 | Baird | Maintained | — | Neutral |
| Jan 21, 2020 | CL King | Upgrade | Neutral | Buy |
| Dec 9, 2019 | Baird | Maintained | — | Neutral |
| Sep 9, 2019 | Pivotal Research | Upgrade | Hold | Buy |
| Aug 27, 2019 | Susquehanna | Upgrade | Neutral | Positive |
| Jan 9, 2019 | Pivotal Research | Downgrade | Buy | Hold |
| Sep 10, 2018 | Macquarie | Maintained | Neutral | Neutral |
| Aug 30, 2018 | Pivotal Research | Upgrade | Hold | Buy |
| Jul 10, 2018 | Jefferies | Downgrade | Buy | Hold |
| Jun 1, 2018 | Piper Sandler | Downgrade | Overweight | Neutral |
| May 29, 2018 | CL King | Downgrade | Buy | Neutral |
| Mar 16, 2018 | Buckingham Research | Maintained | Neutral | Neutral |
| Jan 25, 2018 | Pivotal Research | Initiated | — | Buy |
| Jan 2, 2018 | Jefferies | Upgrade | Hold | Buy |
| Nov 20, 2017 | Buckingham Research | Maintained | — | Neutral |
| Sep 13, 2017 | Morgan Stanley | Maintained | — | Equal-Weight |
| Sep 1, 2017 | Buckingham Research | Maintained | — | Neutral |
| Aug 28, 2017 | Susquehanna | Downgrade | Positive | Neutral |
| May 22, 2017 | B. Riley Securities | Upgrade | Neutral | Buy |
| Apr 26, 2017 | Susquehanna | Upgrade | Neutral | Positive |
| Apr 20, 2017 | Piper Sandler | Upgrade | Neutral | Overweight |
| Oct 19, 2016 | CL King | Downgrade | Strong Buy | Buy |
| Sep 16, 2016 | Susquehanna | Initiated | — | Positive |